Drugs / KRAS-mutated mRNA vaccine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07004244 | Jun 2025 → Dec 2027 expected | cancer | Sichuan University | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | KRAS-mutated mRNA vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07004244 ↗ |
| Modality | Messenger RNA (mRNA) | “mRNA vaccine” NCT07004244 ↗ |
| Target | KRAS | “mRNA vaccines targeting KRAS mutations” NCT07004244 ↗ |